NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 03 03:44PM ET
3.29
Dollar change
-0.08
Percentage change
-2.37
%
Index- P/E307.48 EPS (ttm)0.01 Insider Own29.96% Shs Outstand20.66M Perf Week-2.08%
Market Cap67.96M Forward P/E- EPS next Y-0.04 Insider Trans6.00% Shs Float14.47M Perf Month-16.71%
Enterprise Value18.97M PEG- EPS next Q-0.01 Inst Own38.31% Short Float9.65% Perf Quarter-17.75%
Income0.36M P/S0.28 EPS this Y-6.25% Inst Trans-13.43% Short Ratio9.66 Perf Half Y-34.20%
Sales247.01M P/B0.71 EPS next Y52.94% ROA0.22% Short Interest1.40M Perf YTD-31.74%
Book/sh4.66 P/C1.36 EPS next 5Y- ROE0.36% 52W High6.85 -51.97% Perf Year-18.56%
Cash/sh2.43 P/FCF79.02 EPS past 3/5Y- - ROIC0.37% 52W Low2.90 13.45% Perf 3Y-84.28%
Dividend Est.- EV/EBITDA2.55 Sales past 3/5Y-3.13% -0.17% Gross Margin24.90% Volatility6.05% 5.38% Perf 5Y-90.96%
Dividend TTM- EV/Sales0.08 EPS Y/Y TTM104.54% Oper. Margin0.23% ATR (14)0.19 Perf 10Y-81.38%
Dividend Ex-DateAug 11, 2023 Quick Ratio1.18 Sales Y/Y TTM-10.82% Profit Margin0.14% RSI (14)39.82 Recom4.00
Dividend Gr. 3/5Y- - Current Ratio1.43 EPS Q/Q65.42% SMA20-6.88% Beta0.82 Target Price3.35
Payout- Debt/Eq0.01 Sales Q/Q-18.88% SMA50-9.28% Rel Volume0.82 Prev Close3.37
Employees- LT Debt/Eq0.01 EarningsJul 01 BMO SMA200-21.93% Avg Volume144.55K Price3.29
IPOApr 26, 1999 Option/ShortYes / Yes EPS/Sales Surpr.0.00% 0.00% Trades Volume119,148 Change-2.37%
Date Action Analyst Rating Change Price Target Change
May-25-23Initiated Lake Street Buy $20
Jan-20-22Upgrade Sidoti Neutral → Buy $32
Nov-18-21Initiated Morgan Stanley Underweight $25
Oct-01-21Initiated Jefferies Hold $28
Aug-05-21Resumed Credit Suisse Underperform $22
Jun-03-21Downgrade Sidoti Buy → Neutral $39
Mar-05-21Upgrade Sidoti Neutral → Buy
Jan-27-21Downgrade Sidoti Buy → Neutral
Aug-19-20Upgrade Sidoti Neutral → Buy $37 → $41
Apr-09-20Downgrade Sidoti Buy → Neutral
Jul-03-25 08:30AM
Jul-01-25 08:30AM
Jun-24-25 09:00AM
Jun-16-25 08:30AM
Jun-10-25 06:02PM
04:05PM Loading…
04:05PM
07:30AM
Jun-09-25 09:16AM
May-27-25 04:05PM
08:10AM
May-07-25 09:08AM
Apr-11-25 09:00AM
Apr-09-25 08:00AM
Mar-07-25 04:30AM
Feb-11-25 07:05AM
02:05AM Loading…
02:05AM
Feb-10-25 04:16PM
04:05PM
Feb-07-25 07:09AM
Jan-30-25 04:05PM
Jan-07-25 08:00AM
Dec-23-24 09:50AM
Dec-05-24 09:50AM
Dec-03-24 08:30AM
Nov-30-24 07:19PM
Nov-14-24 10:00AM
09:50AM
Nov-07-24 04:05PM
02:20AM
Nov-06-24 04:48PM
04:05PM Loading…
04:05PM
Nov-05-24 08:08AM
Oct-24-24 02:46PM
08:00AM
Oct-09-24 09:50AM
Sep-27-24 04:17PM
Sep-23-24 09:50AM
Sep-12-24 08:00AM
Aug-21-24 08:30AM
Aug-07-24 12:45PM
Aug-06-24 05:41PM
04:05PM
Aug-05-24 04:05PM
Jul-23-24 08:00AM
Jun-27-24 01:36PM
01:36PM
Jun-24-24 08:00AM
Jun-16-24 07:00AM
Jun-12-24 08:02AM
03:52AM
Jun-11-24 08:53PM
04:25PM
04:05PM
Jun-03-24 08:00AM
May-28-24 08:00AM
May-22-24 04:05PM
May-20-24 08:00AM
Apr-30-24 08:34AM
Apr-29-24 10:25AM
08:15AM
Apr-15-24 12:52PM
08:26AM
08:16AM
Apr-04-24 01:45PM
Mar-18-24 03:44AM
Mar-13-24 08:17AM
Feb-28-24 06:00PM
Feb-22-24 04:21AM
Feb-16-24 08:30AM
Feb-15-24 01:34PM
08:30AM
Feb-14-24 01:47AM
Feb-09-24 09:26AM
06:05AM
Feb-08-24 04:56PM
04:01PM
Jan-29-24 08:30AM
Jan-08-24 05:46PM
Dec-19-23 06:36PM
Dec-16-23 07:00AM
Dec-08-23 04:35PM
Dec-07-23 02:56PM
Nov-27-23 12:26PM
Nov-13-23 10:40AM
Nov-06-23 04:50PM
Oct-31-23 08:28AM
08:10AM
05:26AM
Oct-30-23 05:56PM
04:43PM
04:01PM
Oct-19-23 08:30AM
Oct-12-23 06:20PM
Oct-11-23 01:18PM
Sep-19-23 09:00AM
Sep-07-23 04:01PM
07:30AM
Aug-06-23 08:05AM
Aug-04-23 06:04AM
Aug-01-23 07:09AM
PetMed Express, Inc. provides markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. Its non-prescription medications include flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies. The prescription medications include heartworm preventatives, arthritis, thyroid, diabetes and pain medications, heart/blood pressure, and other specialty medications, and generic substitutes. The company was founded in January 1996 and is headquartered in Delray Beach, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Silvercape Investments Ltd10% OwnerJul 02 '25Buy3.222,8179,0712,311,230Jul 03 10:19 AM
Silvercape Investments Ltd10% OwnerJul 01 '25Buy3.216942,2282,308,413Jul 02 02:41 PM
NINA CAPITAL HOLDINGS INC.10% OwnerJun 03 '25Buy3.9425,00098,3752,550,000Jun 04 04:15 PM
NINA CAPITAL HOLDINGS INC.10% OwnerMay 21 '25Buy3.8625,00096,5002,525,000May 23 04:15 PM
Silvercape Investments Ltd10% OwnerMay 20 '25Buy3.957,40129,2342,307,719May 22 10:55 AM
Campos Sandra YvetteCEO & PresidentApr 30 '25Sale3.3160,463200,090578,524May 02 08:57 PM
NINA CAPITAL HOLDINGS INC.10% OwnerMar 18 '25Buy4.08100,000408,5002,500,000Mar 19 04:19 PM
NINA CAPITAL HOLDINGS INC.10% OwnerMar 10 '25Buy4.11100,000411,0002,400,000Mar 11 04:15 PM
NINA CAPITAL HOLDINGS INC.10% OwnerMar 03 '25Buy4.3350,000216,2502,300,000Mar 04 04:16 PM
NINA CAPITAL HOLDINGS INC.10% OwnerFeb 03 '25Buy4.8225,000120,5002,250,000Feb 04 06:01 PM
NINA CAPITAL HOLDINGS INC.10% OwnerJan 24 '25Buy4.9525,000123,6752,200,000Jan 28 04:15 PM
NINA CAPITAL HOLDINGS INC.10% OwnerJan 27 '25Buy4.6325,000115,8752,225,000Jan 28 04:15 PM
NINA CAPITAL HOLDINGS INC.10% OwnerJan 07 '25Buy4.9725,000124,3752,175,000Jan 10 04:05 PM
NINA CAPITAL HOLDINGS INC.10% OwnerDec 16 '24Buy5.6632,000180,9602,150,000Dec 18 04:15 PM
NINA CAPITAL HOLDINGS INC.10% OwnerDec 06 '24Buy5.5540,000222,0002,118,000Dec 10 04:15 PM
Campbell Leslie C.G.DirectorDec 05 '24Buy5.4415,00081,65030,000Dec 06 09:06 PM
Campbell Leslie C.G.DirectorDec 05 '24Buy5.4215,00081,35485,000Dec 06 09:06 PM
Campbell Leslie C.G.DirectorDec 04 '24Buy5.4015,00081,00015,000Dec 06 09:06 PM
Campbell Leslie C.G.DirectorDec 04 '24Buy5.3815,00080,63270,000Dec 06 09:06 PM
NINA CAPITAL HOLDINGS INC.10% OwnerSep 09 '24Buy3.3412,50041,7502,078,000Oct 18 08:18 PM
Smith Jacqueline PaulaVice President of PeopleAug 15 '24Sale3.196011,91720,099Aug 19 05:05 PM
Last Close
Jul 03 04:00PM ET
67.43
Dollar change
+0.83
Percentage change
1.25
%
CVS CVS Health Corp daily Stock Chart
IndexS&P 500 P/E16.11 EPS (ttm)4.19 Insider Own0.15% Shs Outstand1.27B Perf Week-1.04%
Market Cap85.30B Forward P/E9.56 EPS next Y7.05 Insider Trans-66.26% Shs Float1.26B Perf Month6.04%
Enterprise Value153.98B PEG1.17 EPS next Q1.45 Inst Own86.66% Short Float1.48% Perf Quarter-0.94%
Income5.28B P/S0.23 EPS this Y13.02% Inst Trans3.38% Short Ratio1.90 Perf Half Y53.46%
Sales378.85B P/B1.11 EPS next Y15.13% ROA2.09% Short Interest18.71M Perf YTD50.21%
Book/sh60.96 P/C6.71 EPS next 5Y13.80% ROE7.00% 52W High72.51 -7.01% Perf Year15.96%
Cash/sh10.05 P/FCF14.36 EPS past 3/5Y-14.99% -6.37% ROIC3.51% 52W Low43.56 54.80% Perf 3Y-27.65%
Dividend Est.2.32 (3.45%) EV/EBITDA9.53 Sales past 3/5Y8.48% 7.75% Gross Margin14.02% Volatility2.10% 2.04% Perf 5Y6.27%
Dividend TTM2.66 (3.94%) EV/Sales0.41 EPS Y/Y TTM-26.54% Oper. Margin3.05% ATR (14)1.57 Perf 10Y-35.79%
Dividend Ex-DateApr 22, 2025 Quick Ratio0.63 Sales Y/Y TTM4.84% Profit Margin1.39% RSI (14)54.58 Recom1.67
Dividend Gr. 3/5Y9.07% 5.87% Current Ratio0.82 EPS Q/Q60.22% SMA201.21% Beta0.60 Target Price79.26
Payout72.76% Debt/Eq1.06 Sales Q/Q6.96% SMA503.51% Rel Volume0.38 Prev Close66.60
Employees300000 LT Debt/Eq0.96 EarningsMay 01 BMO SMA20011.47% Avg Volume9.87M Price67.43
IPOOct 01, 1952 Option/ShortYes / Yes EPS/Sales Surpr.32.15% 0.97% Trades Volume3,770,987 Change1.25%
Date Action Analyst Rating Change Price Target Change
Feb-13-25Upgrade Leerink Partners Market Perform → Outperform $55 → $75
Feb-12-25Upgrade Cantor Fitzgerald Neutral → Overweight
Jan-30-25Upgrade Edward Jones Hold → Buy
Dec-03-24Upgrade Deutsche Bank Hold → Buy $66
Nov-18-24Upgrade Wells Fargo Equal Weight → Overweight $60 → $66
Oct-10-24Upgrade Barclays Equal Weight → Overweight $63 → $82
Oct-04-24Upgrade TD Cowen Hold → Buy $59 → $85
May-30-24Initiated Robert W. Baird Neutral $61
May-07-24Downgrade TD Cowen Buy → Hold $99 → $59
May-02-24Downgrade UBS Buy → Neutral $85 → $60
Today 08:44AM
Jul-03-25 11:19AM
08:32AM
Jul-02-25 05:45PM
12:10PM
10:27AM Loading…
10:27AM
09:32AM
09:30AM
09:00AM
08:59AM
08:50AM
07:15AM
Jul-01-25 06:44PM
04:42PM
03:25PM
12:25PM Loading…
12:25PM
Jun-30-25 03:00PM
11:07AM
10:27AM
09:00AM
Jun-28-25 01:22AM
Jun-27-25 11:40AM
11:36AM
10:10AM
09:40AM
09:04AM
07:00AM
03:00AM
Jun-26-25 10:55AM
10:00AM
08:23AM Loading…
08:23AM
05:16AM
02:54AM
Jun-25-25 06:08PM
Jun-24-25 05:45PM
10:43AM
09:20AM
Jun-23-25 11:32AM
11:20AM
09:40AM
09:40AM
07:58AM
07:54AM
05:01AM
Jun-20-25 11:54PM
11:40AM
11:36AM
Jun-19-25 11:35AM
09:00AM
Jun-18-25 09:55AM
09:52AM
09:36AM
08:08AM
12:01AM
Jun-17-25 03:00PM
11:39AM
11:22AM
09:02AM
08:59AM
07:00AM
06:20AM
Jun-16-25 06:38PM
05:15PM
11:14AM
11:09AM
09:29AM
04:00AM
Jun-13-25 02:10PM
12:37PM
04:51AM
Jun-12-25 03:00PM
08:01AM
Jun-11-25 11:40AM
10:28AM
09:40AM
Jun-09-25 11:55AM
Jun-06-25 12:26PM
12:13PM
10:09AM
Jun-05-25 12:07PM
11:18AM
09:40AM
08:31AM
Jun-04-25 02:01PM
12:31PM
12:26PM
09:00AM
08:31AM
04:57AM
Jun-03-25 12:10PM
12:10PM
11:41AM
10:24AM
Jun-02-25 08:38AM
May-30-25 10:14AM
09:32AM
09:31AM
May-29-25 10:08AM
10:06AM
09:29AM
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SANSONE GUY PDirectorJun 05 '25Buy63.701,570100,00912,007Jun 09 08:22 AM
ROBBINS LARRYDirectorMay 02 '25Sale67.862,276,068154,444,7589,670,731May 06 04:15 PM
ROBBINS LARRYDirectorMay 05 '25Sale67.411,323,93289,249,9458,346,799May 06 04:15 PM
ROBBINS LARRYDirectorMay 06 '25Sale66.67150,00010,000,7108,196,799May 06 04:15 PM
Shah Prem SEVP and Group PresidentMar 17 '25Option Exercise62.2184652,63043,190Mar 18 04:51 PM
Clark James DavidSVP, Cont & Chief Acct OfficerMar 05 '25Option Exercise62.217,513467,38415,907Mar 07 04:56 PM
Clark James DavidSVP, Cont & Chief Acct OfficerMar 05 '25Sale66.357,513498,4888,394Mar 07 04:56 PM
Clark James DavidOfficerMar 05 '25Proposed Sale66.357,513498,489Mar 05 05:25 PM
Mahoney Michael FDirectorFeb 18 '25Buy66.7030,0002,001,00039,356Feb 19 12:35 PM
GRDN Guardian Pharmacy Services Inc daily Stock Chart
IndexRUT P/E- EPS (ttm)-1.42 Insider Own68.34% Shs Outstand22.72M Perf Week-1.42%
Market Cap1.35B Forward P/E20.71 EPS next Y1.01 Insider Trans-25.96% Shs Float20.49M Perf Month-4.36%
Enterprise Value1.37B PEG- EPS next Q0.19 Inst Own15.25% Short Float2.72% Perf Quarter-3.16%
Income-89.97M P/S1.05 EPS this Y147.27% Inst Trans-28.18% Short Ratio2.28 Perf Half Y2.81%
Sales1.28B P/B8.45 EPS next Y20.32% ROA- Short Interest0.56M Perf YTD2.91%
Book/sh2.47 P/C96.39 EPS next 5Y- ROE- 52W High26.91 -22.52% Perf Year-
Cash/sh0.22 P/FCF27.89 EPS past 3/5Y- - ROIC-50.58% 52W Low14.16 47.25% Perf 3Y-
Dividend Est.- EV/EBITDA- Sales past 3/5Y15.75% - Gross Margin19.78% Volatility3.48% 4.12% Perf 5Y-
Dividend TTM- EV/Sales1.07 EPS Y/Y TTM- Oper. Margin-4.51% ATR (14)0.94 Perf 10Y-
Dividend Ex-Date- Quick Ratio0.84 Sales Y/Y TTM- Profit Margin-7.02% RSI (14)46.92 Recom1.33
Dividend Gr. 3/5Y- - Current Ratio1.14 EPS Q/Q- SMA201.77% Beta- Target Price27.33
Payout- Debt/Eq0.18 Sales Q/Q19.57% SMA50-7.57% Rel Volume0.32 Prev Close20.59
Employees3400 LT Debt/Eq0.14 EarningsMay 12 AMC SMA200-1.52% Avg Volume244.81K Price20.85
IPOSep 26, 2024 Option/ShortNo / Yes EPS/Sales Surpr.-31.82% 2.52% Trades Volume78,441 Change1.26%
Date Action Analyst Rating Change Price Target Change
Oct-21-24Initiated Truist Buy $22
Oct-21-24Initiated Raymond James Outperform $21
Jun-10-25 10:03AM
Jun-02-25 08:07AM
May-22-25 11:15PM
May-20-25 04:16PM
May-14-25 10:03AM
03:09AM Loading…
May-13-25 03:09AM
May-12-25 04:23PM
04:05PM
May-08-25 04:05PM
Apr-30-25 04:12PM
Apr-14-25 10:03AM
Apr-08-25 10:03AM
Mar-27-25 06:32AM
03:02AM
Mar-26-25 04:18PM
04:01PM Loading…
04:01PM
Mar-22-25 11:00AM
Mar-03-25 06:00AM
Feb-17-25 04:05PM
Dec-17-24 09:00AM
Nov-12-24 04:41PM
04:05PM
Oct-31-24 08:00AM
Oct-30-24 08:00AM
Oct-21-24 02:54PM
Oct-08-24 09:02AM
Sep-26-24 10:50AM
Sep-25-24 09:45PM
09:10PM
Guardian Pharmacy Services, Inc. engages in the provision of client service and resident care to long-term care communities. It offers assisted living and skilled nursing, group homes, behavioral health and organizations that serve individuals with intellectual and developmental disabilities. The company was founded by Fred Burke, David Morris, and Kendall Forbes on July 21, 2003 and is headquartered in Atlanta, GA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BINDLEY WILLIAM EDirectorMay 27 '25Sale20.163,508,90570,739,5252,591,271May 29 04:15 PM
BINDLEY WILLIAM EDirectorMay 28 '25Sale20.16651,45413,133,3131,939,817May 29 04:15 PM
Salentine Thomas J JrDirectorMay 27 '25Sale20.163,508,90570,739,5252,591,271May 29 04:15 PM
Salentine Thomas J JrDirectorMay 28 '25Sale20.16651,45413,133,3131,939,817May 29 04:15 PM
Ackerman JohnDirectorMay 27 '25Sale20.161,084,27621,859,004200,099May 29 04:15 PM
Ackerman JohnDirectorMay 28 '25Sale20.16201,3034,058,268149,794May 29 04:15 PM
Burke FredSee RemarksMay 27 '25Sale20.16747,10215,061,576551,724May 29 04:15 PM
Morris David KSee RemarksMay 27 '25Sale20.16369,2127,443,314283,042May 29 04:15 PM
Burke FredSee RemarksMay 28 '25Sale20.16138,7052,796,293413,019May 29 04:15 PM
Morris David KSee RemarksMay 28 '25Sale20.1668,5471,381,908214,495May 29 04:15 PM
Forbes KendallSee RemarksMay 27 '25Sale20.16350,0587,057,169268,897May 29 04:15 PM
Forbes KendallSee RemarksMay 28 '25Sale20.1664,9911,310,219203,906May 29 04:15 PM
Bindley Capital Partners I, LL10% OwnerMay 27 '25Sale20.163,508,90570,739,5252,591,271May 29 03:06 PM
Bindley Capital Partners I, LL10% OwnerMay 28 '25Sale20.16651,45413,133,3131,939,817May 29 03:06 PM
COSLER STEVEN DDirectorNov 19 '24Buy21.227,000148,54017,713Nov 20 04:05 PM
Salentine Thomas J JrDirectorSep 27 '24Buy14.0035,714499,99635,714Oct 01 05:48 PM
Patchett Mary SueDirectorSep 27 '24Buy14.003,57149,9943,571Oct 01 05:46 PM
LEWIS RANDALL JDirectorSep 27 '24Buy14.003,57149,9943,571Oct 01 05:43 PM
COSLER STEVEN DDirectorSep 27 '24Buy14.007,14299,9887,142Oct 01 05:43 PM
WBA Walgreens Boots Alliance Inc daily Stock Chart
IndexS&P 500 P/E- EPS (ttm)-7.29 Insider Own17.66% Shs Outstand865.20M Perf Week0.79%
Market Cap9.93B Forward P/E7.74 EPS next Y1.48 Insider Trans0.00% Shs Float712.72M Perf Month2.14%
Enterprise Value39.23B PEG- EPS next Q0.25 Inst Own61.21% Short Float2.69% Perf Quarter2.59%
Income-6298.00M P/S0.06 EPS this Y-40.33% Inst Trans-2.33% Short Ratio1.81 Perf Half Y23.87%
Sales154.58B P/B1.38 EPS next Y-13.72% ROA-8.27% Short Interest19.19M Perf YTD22.94%
Book/sh8.30 P/C11.96 EPS next 5Y-17.11% ROE-60.49% 52W High13.25 -13.43% Perf Year-0.95%
Cash/sh0.96 P/FCF17.12 EPS past 3/5Y- - ROIC-18.40% 52W Low8.08 41.96% Perf 3Y-72.00%
Dividend Est.0.75 (6.54%) EV/EBITDA13.87 Sales past 3/5Y3.67% 1.53% Gross Margin15.55% Volatility0.58% 0.61% Perf 5Y-72.14%
Dividend TTM0.50 (4.36%) EV/Sales0.25 EPS Y/Y TTM-8.21% Oper. Margin0.26% ATR (14)0.08 Perf 10Y-86.72%
Dividend Ex-DateNov 18, 2024 Quick Ratio0.32 Sales Y/Y TTM6.22% Profit Margin-4.07% RSI (14)63.88 Recom2.85
Dividend Gr. 3/5Y-13.19% -7.13% Current Ratio0.60 EPS Q/Q-150.83% SMA200.82% Beta0.77 Target Price12.09
Payout- Debt/Eq4.18 Sales Q/Q7.25% SMA502.09% Rel Volume0.63 Prev Close11.49
Employees312000 LT Debt/Eq3.77 EarningsJun 26 BMO SMA20010.99% Avg Volume10.59M Price11.47
IPODec 31, 2014 Option/ShortYes / Yes EPS/Sales Surpr.16.14% 5.83% Trades Volume6,656,752 Change-0.17%
Date Action Analyst Rating Change Price Target Change
Feb-28-25Downgrade Deutsche Bank Hold → Sell $11 → $9
Feb-26-24Initiated Leerink Partners Market Perform $23
Feb-20-24Downgrade HSBC Securities Hold → Reduce
Jan-03-24Initiated Barclays Underweight $21
Dec-22-23Initiated HSBC Securities Hold $27
Oct-23-23Upgrade JP Morgan Neutral → Overweight $27 → $30
Jul-03-23Reiterated Morgan Stanley Underweight $37 → $27
Jun-28-23Downgrade Deutsche Bank Buy → Hold $46 → $34
Feb-23-23Initiated Loop Capital Buy $45
Nov-23-22Resumed Morgan Stanley Underweight $39
Today 08:44AM
Jul-03-25 03:55AM
Jul-01-25 08:40AM
Jun-30-25 11:07AM
12:01AM
01:40PM Loading…
Jun-29-25 01:40PM
Jun-27-25 05:26PM
12:21PM
09:22AM
05:52AM
Jun-26-25 06:02PM
04:35PM
12:22PM
11:03AM
10:54AM
09:52AM Loading…
09:52AM
09:30AM
09:05AM
08:10AM
08:06AM
07:50AM
07:42AM
07:19AM
07:14AM
07:12AM
07:06AM
07:06AM
07:00AM
04:58AM
04:55AM
04:18AM Loading…
04:18AM
Jun-25-25 01:58PM
09:34AM
03:27AM
Jun-24-25 11:00PM
08:00AM
06:30AM
04:56AM
Jun-23-25 09:15AM
Jun-22-25 02:00PM
10:21AM
07:35AM
06:00AM
Jun-20-25 10:02AM
08:55AM
08:10AM
Jun-18-25 09:40AM
09:40AM
09:40AM
09:40AM
09:40AM
09:40AM
09:40AM
09:40AM
09:40AM
09:40AM
07:10AM
Jun-17-25 03:00PM
11:22AM
07:00AM
Jun-16-25 05:15PM
08:59AM
Jun-12-25 09:00AM
Jun-11-25 10:01PM
10:56AM
05:30AM
04:15AM
Jun-10-25 01:26PM
Jun-09-25 11:30PM
Jun-06-25 01:21PM
Jun-05-25 05:15PM
08:31AM
Jun-02-25 05:45PM
06:20AM
12:02AM
May-27-25 05:45PM
09:25AM
May-22-25 08:26AM
May-21-25 05:45PM
07:20AM
May-20-25 05:33PM
01:46PM
10:27AM
09:00AM
May-19-25 10:22AM
07:19AM
May-16-25 09:59AM
May-15-25 05:45PM
08:50AM
May-14-25 03:00PM
07:51AM
May-13-25 06:20PM
May-12-25 03:54PM
May-09-25 06:46PM
May-08-25 05:45PM
11:30AM
May-06-25 12:35AM
May-05-25 06:11PM
May-02-25 05:45PM
Apr-30-25 03:22AM
Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Pessina StefanoExecutive Chairman of BoardApr 27 '25Buy11.01832,2589,163,161145,621,079Apr 29 08:49 PM
Pessina StefanoExecutive Chairman of BoardApr 27 '25Sale11.01832,2589,163,161657,308Apr 29 08:49 PM
Walgreens Boots Alliance, Inc.Former 10% ownerFeb 18 '25Sale21.1612,000,000253,920,00011,239,996Feb 20 04:30 PM
Walgreens Boots Alliance, Inc.10% OwnerFeb 06 '25Sale244.511,286,376314,531,79612,570,000Feb 10 07:35 PM
Walgreens Boots Alliance HoldiAffiliateFeb 06 '25Proposed Sale246.131,081,885266,284,355Feb 06 07:55 PM
Walgreens Boots Alliance, Inc.10% OwnerSep 11 '24Sale11.1311,619,998129,330,57823,239,996Sep 13 07:04 PM
Walgreens Boots Alliance, Inc.10% OwnerAug 01 '24Sale240.564,438,1711,067,646,41619,980,000Aug 05 06:44 PM
Walgreens Boots Alliance HoldiAffiliateAug 01 '24Proposed Sale244.463,398,929830,902,183Aug 01 08:56 PM
BTSG BrightSpring Health Services Inc daily Stock Chart
IndexRUT P/E78.61 EPS (ttm)0.28 Insider Own45.73% Shs Outstand175.18M Perf Week-4.16%
Market Cap3.89B Forward P/E20.89 EPS next Y1.06 Insider Trans-35.10% Shs Float95.41M Perf Month-6.47%
Enterprise Value6.56B PEG2.51 EPS next Q0.18 Inst Own52.27% Short Float16.07% Perf Quarter21.67%
Income57.23M P/S0.34 EPS this Y53.28% Inst Trans-2.61% Short Ratio6.15 Perf Half Y30.04%
Sales11.57B P/B2.30 EPS next Y23.33% ROA0.65% Short Interest15.33M Perf YTD29.89%
Book/sh9.63 P/C74.30 EPS next 5Y31.33% ROE2.30% 52W High25.57 -13.49% Perf Year101.82%
Cash/sh0.30 P/FCF22.81 EPS past 3/5Y- 60.10% ROIC1.33% 52W Low10.15 117.93% Perf 3Y-
Dividend Est.- EV/EBITDA12.33 Sales past 3/5Y18.93% 20.01% Gross Margin13.46% Volatility3.65% 4.17% Perf 5Y-
Dividend TTM- EV/Sales0.57 EPS Y/Y TTM128.30% Oper. Margin2.89% ATR (14)0.89 Perf 10Y-
Dividend Ex-Date- Quick Ratio1.37 Sales Y/Y TTM23.40% Profit Margin0.49% RSI (14)46.68 Recom1.15
Dividend Gr. 3/5Y- - Current Ratio1.73 EPS Q/Q151.42% SMA20-1.81% Beta2.38 Target Price28.10
Payout- Debt/Eq1.61 Sales Q/Q11.70% SMA500.26% Rel Volume0.40 Prev Close22.00
Employees600 LT Debt/Eq1.56 EarningsMay 02 BMO SMA20016.20% Avg Volume2.50M Price22.12
IPOJan 26, 2024 Option/ShortYes / Yes EPS/Sales Surpr.108.79% 6.11% Trades Volume1,008,367 Change0.55%
Date Action Analyst Rating Change Price Target Change
Jun-23-25Initiated TD Cowen Buy $37
Dec-12-24Initiated CJS Securities Market Outperform
Oct-11-24Initiated KeyBanc Capital Markets Sector Weight
Jun-21-24Initiated BTIG Research Buy $15
Mar-06-24Initiated HSBC Securities Buy $13
Feb-27-24Upgrade Deutsche Bank Hold → Buy $11.50
Feb-20-24Initiated Wells Fargo Overweight $15
Feb-20-24Initiated UBS Buy $15
Feb-20-24Initiated Morgan Stanley Overweight $18
Feb-20-24Initiated Leerink Partners Outperform $15
Today 01:48AM
Jul-03-25 01:51PM
Jul-02-25 11:34AM
Jul-01-25 08:03AM
Jun-30-25 02:29PM
05:44PM Loading…
Jun-26-25 05:44PM
03:24PM
03:00PM
Jun-25-25 10:03AM
Jun-20-25 08:44AM
Jun-18-25 04:30PM
Jun-17-25 08:59AM
Jun-16-25 03:57PM
11:09AM
07:34AM
11:19AM Loading…
Jun-13-25 11:19AM
Jun-11-25 09:55AM
Jun-10-25 09:59PM
04:16PM
03:00PM
Jun-06-25 12:36PM
Jun-05-25 07:55AM
Jun-03-25 08:00AM
May-30-25 11:50AM
May-29-25 09:55AM
May-26-25 08:50AM
May-24-25 08:00AM
May-23-25 09:40AM
May-22-25 11:33PM
12:51PM
09:43AM Loading…
May-19-25 09:43AM
May-16-25 10:52AM
09:05AM
May-14-25 07:24AM
06:21AM
May-09-25 03:14PM
12:00PM
11:35AM
May-08-25 12:31PM
12:20PM
11:39AM
10:00AM
08:50AM
07:31AM
May-07-25 09:40AM
May-06-25 05:34AM
12:32AM
May-03-25 03:04AM
02:03AM
May-02-25 03:12PM
07:15AM
06:00AM
May-01-25 09:21AM
Apr-25-25 10:00AM
Apr-17-25 05:07AM
Apr-10-25 04:05PM
Apr-01-25 10:23AM
Mar-30-25 05:45PM
Mar-28-25 05:03AM
Mar-18-25 09:01AM
Mar-12-25 05:02AM
Mar-07-25 02:09AM
01:03AM
Mar-06-25 07:10AM
06:05AM
06:00AM
Mar-05-25 05:20PM
08:05AM
07:07AM
Feb-22-25 03:59PM
Feb-14-25 03:02PM
01:11PM
Feb-13-25 01:13PM
04:01AM
Feb-11-25 08:30AM
04:03AM
Feb-06-25 04:05PM
Feb-02-25 04:31PM
Jan-22-25 05:36AM
02:00AM
01:07AM
Jan-21-25 12:52PM
Jan-20-25 06:30PM
Jan-09-25 05:05PM
Jan-07-25 10:50AM
Jan-02-25 12:00PM
Dec-11-24 04:05PM
Nov-26-24 05:00PM
Nov-21-24 04:05PM
Nov-06-24 04:35PM
Nov-02-24 03:01AM
Nov-01-24 06:00AM
Oct-31-24 09:04AM
Oct-12-24 05:48PM
Oct-07-24 03:03PM
Oct-01-24 04:05PM
Sep-30-24 07:30AM
Sep-14-24 02:17AM
Sep-13-24 04:00PM
Sep-12-24 11:17AM
BrightSpring Health Services, Inc. engages in the provision of a platform of complementary health services delivering and pharmacy solutions for complex populations in home and community settings. It operates under the Pharmacy Solutions and Provider Services segments. The Pharmacy Solutions segment includes infusion and specialty pharmacy, and home and community pharmacy. The Provider Services segment is involved in home health care and community and rehab care. The company was founded in 1974 and is headquartered in Louisville, KY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KKR Group Partnership L.P.10% OwnerJun 24 '25Sale21.152,100,00044,418,99077,096,337Jun 26 04:31 PM
KKR Phoenix Aggregator L.P.10% OwnerJun 24 '25Sale21.152,100,00044,418,99077,096,337Jun 26 04:30 PM
KKR Group Partnership L.P.10% OwnerJun 12 '25Sale21.1513,288,101281,068,58479,671,883Jun 16 08:08 PM
KKR Phoenix Aggregator L.P.10% OwnerJun 12 '25Sale21.1513,288,101281,068,58479,671,883Jun 16 08:08 PM
Phipps Jennifer AChief Accounting OfficerJun 12 '25Option Exercise6.3715,61699,474245,646Jun 13 04:04 PM
Phipps Jennifer AChief Accounting OfficerJun 12 '25Sale21.7515,616339,648230,030Jun 13 04:04 PM
Nalley Lisa ASee RemarksJun 12 '25Option Exercise6.3714,41591,824145,565Jun 13 04:03 PM
Nalley Lisa ASee RemarksJun 12 '25Sale21.7514,415313,526131,150Jun 13 04:03 PM
ROUSSEAU JON BSee RemarksJun 12 '25Option Exercise6.37531,8403,387,8211,715,973Jun 13 04:03 PM
ROUSSEAU JON BSee RemarksJun 12 '25Sale21.75531,84011,567,5201,184,133Jun 13 04:03 PM
McMaude Michael ASee RemarksJun 12 '25Sale21.75119,2982,594,732207,590Jun 13 04:02 PM
Barnes Robert AllenPresident, Community LivingJun 12 '25Option Exercise6.3727,606175,85069,999Jun 13 04:02 PM
Barnes Robert AllenPresident, Community LivingJun 12 '25Sale21.7530,730668,37839,269Jun 13 04:02 PM
Walgreens Boots Alliance, Inc.Former 10% ownerFeb 18 '25Sale21.1612,000,000253,920,00011,239,996Feb 20 04:30 PM
Walgreen Co.10% OwnerFeb 18 '25Proposed Sale22.1512,000,000265,800,000Feb 18 09:07 PM
Walgreens Boots Alliance, Inc.10% OwnerSep 11 '24Sale11.1311,619,998129,330,57823,239,996Sep 13 07:04 PM
KKR Group Partnership L.P.10% OwnerSep 11 '24Buy11.1311,619,998129,330,57892,959,984Sep 13 04:44 PM
KKR Phoenix Aggregator L.P.10% OwnerSep 11 '24Buy11.1311,619,998129,330,57892,959,984Sep 13 04:36 PM
Last Close
Jul 03 04:00PM ET
296.23
Dollar change
+5.06
Percentage change
1.74
%
COR Cencora Inc daily Stock Chart
IndexS&P 500 P/E34.38 EPS (ttm)8.62 Insider Own5.33% Shs Outstand193.78M Perf Week-0.12%
Market Cap57.42B Forward P/E17.04 EPS next Y17.39 Insider Trans-11.97% Shs Float183.50M Perf Month1.61%
Enterprise Value63.33B PEG2.96 EPS next Q3.82 Inst Own93.59% Short Float3.61% Perf Quarter5.98%
Income1.69B P/S0.19 EPS this Y14.98% Inst Trans1.82% Short Ratio3.77 Perf Half Y31.83%
Sales310.23B P/B56.68 EPS next Y9.90% ROA2.51% Short Interest6.62M Perf YTD31.85%
Book/sh5.23 P/C27.21 EPS next 5Y11.63% ROE161.58% 52W High309.35 -4.24% Perf Year32.52%
Cash/sh10.89 P/FCF16.06 EPS past 3/5Y0.66% 13.29% ROIC20.91% 52W Low218.65 35.48% Perf 3Y106.88%
Dividend Est.2.20 (0.74%) EV/EBITDA14.79 Sales past 3/5Y11.16% 10.36% Gross Margin2.94% Volatility2.26% 1.83% Perf 5Y198.68%
Dividend TTM2.16 (0.73%) EV/Sales0.20 EPS Y/Y TTM-5.92% Oper. Margin1.03% ATR (14)5.84 Perf 10Y175.28%
Dividend Ex-DateMay 16, 2025 Quick Ratio0.52 Sales Y/Y TTM12.18% Profit Margin0.55% RSI (14)54.92 Recom1.84
Dividend Gr. 3/5Y5.04% 4.98% Current Ratio0.87 EPS Q/Q75.92% SMA201.15% Beta0.59 Target Price333.21
Payout27.07% Debt/Eq7.76 Sales Q/Q10.29% SMA501.96% Rel Volume0.35 Prev Close291.17
Employees46000 LT Debt/Eq7.00 EarningsMay 07 BMO SMA20015.31% Avg Volume1.76M Price296.23
IPOApr 04, 1995 Option/ShortYes / Yes EPS/Sales Surpr.7.42% -0.24% Trades Volume614,990 Change1.74%
Date Action Analyst Rating Change Price Target Change
Jun-03-25Upgrade Wells Fargo Equal Weight → Overweight $337
Dec-04-24Resumed Mizuho Outperform $280
Sep-18-24Downgrade BofA Securities Buy → Neutral $275 → $245
Feb-26-24Initiated Leerink Partners Outperform $261
Jan-03-24Initiated Barclays Overweight $242
Dec-14-23Initiated Wells Fargo Equal Weight $213
Mar-31-23Initiated Citigroup Buy $185
Jan-31-23Resumed Evercore ISI Outperform $185
Oct-11-22Upgrade BofA Securities Neutral → Buy $160 → $169
Aug-22-22Resumed Morgan Stanley Equal-Weight
Today 09:45AM
Jul-03-25 09:23AM
09:13AM
07:30AM
Jul-02-25 10:03AM
10:01AM Loading…
10:01AM
08:47AM
08:21AM
08:17AM
12:07AM
Jul-01-25 09:14AM
08:12AM
Jun-30-25 11:39PM
09:06AM
08:30AM
07:59AM Loading…
Jun-27-25 07:59AM
Jun-25-25 10:03AM
Jun-24-25 09:33AM
08:35AM
Jun-23-25 09:50AM
Jun-19-25 08:35AM
08:18AM
08:17AM
Jun-18-25 09:22AM
08:28AM
Jun-17-25 08:39AM
Jun-16-25 11:19AM
08:35AM
08:27AM
08:25AM
12:13PM Loading…
Jun-13-25 12:13PM
Jun-11-25 08:35AM
04:29AM
Jun-10-25 08:06AM
Jun-09-25 06:20AM
Jun-05-25 12:26PM
08:52AM
06:20AM
Jun-04-25 12:33PM
08:34AM
Jun-03-25 08:08AM
Jun-02-25 09:40AM
08:12AM
May-30-25 09:32AM
09:31AM
May-29-25 09:29AM
May-28-25 12:18PM
09:14AM
07:30AM
May-27-25 09:08AM
May-23-25 04:03PM
10:47AM
06:20AM
May-22-25 09:54AM
06:20AM
May-21-25 01:08PM
07:17AM
06:20AM
May-19-25 09:58AM
07:02AM
06:54AM
May-18-25 06:56AM
May-16-25 08:00AM
07:59AM
06:20AM
May-14-25 06:20AM
May-12-25 08:01AM
May-09-25 09:50AM
May-08-25 05:05PM
09:15AM
May-07-25 05:00PM
03:40PM
01:25PM
01:25PM
01:09PM
10:57AM
10:55AM
09:40AM
07:40AM
06:30AM
May-06-25 10:13AM
06:20AM
May-05-25 11:12AM
07:25AM
May-02-25 09:00PM
11:05AM
09:15AM
Apr-30-25 10:17AM
10:01AM
09:40AM
Apr-28-25 12:23PM
11:22AM
09:12AM
08:45AM
08:08AM
01:55AM
Apr-25-25 08:02AM
08:00AM
Apr-24-25 06:14PM
02:50PM
Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments. The U.S. Healthcare Solutions segment is involved in the offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a wide variety of healthcare providers. The International Healthcare Solutions segment includes businesses that focus on international pharmaceutical wholesale and related service operations, and global commercialization services. The company was founded by Emil P. Martini in 1947 and is headquartered in Conshohocken, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
COLLIS STEVEN HExecutive ChairmanJun 24 '25Option Exercise86.0912,5791,082,926326,492Jun 25 04:03 PM
COLLIS STEVEN HExecutive ChairmanJun 24 '25Sale292.6214,5794,266,107311,913Jun 25 04:03 PM
COLLIS STEVEN HDirectorJun 24 '25Proposed Sale292.6214,5794,266,107Jun 24 10:21 AM
Battaglia SilvanaExecutive Vice PresidentJun 18 '25Sale297.404,0771,212,52011,297Jun 20 04:06 PM
Mauch Robert P.President & CEOJun 18 '25Option Exercise86.093,225277,64049,063Jun 20 04:04 PM
Mauch Robert P.President & CEOJun 18 '25Sale295.304,9691,467,34644,094Jun 20 04:04 PM
Lon GreenbergBoard of directorsJun 18 '25Proposed Sale293.201,000293,200Jun 18 04:40 PM
Battaglia SilvanaOfficerJun 18 '25Proposed Sale297.414,0771,212,520Jun 18 12:58 PM
Mauch Robert P.OfficerJun 18 '25Proposed Sale295.304,9691,467,346Jun 18 09:50 AM
Krikorian LazarusSVP & Chief Accounting OfficerMay 29 '25Sale288.963,000866,88117,154Jun 02 04:08 PM
Krikorian LazarusOfficerMay 29 '25Proposed Sale288.963,000866,881May 29 11:37 AM
Mauch Robert P.President & CEOMay 19 '25Option Exercise86.093,225277,64050,807May 21 04:04 PM
Mauch Robert P.President & CEOMay 19 '25Sale291.434,9691,448,11645,838May 21 04:04 PM
COLLIS STEVEN HExecutive ChairmanMay 20 '25Option Exercise86.0912,5781,082,840328,491May 21 04:00 PM
COLLIS STEVEN HExecutive ChairmanMay 20 '25Sale293.8414,5784,283,600313,913May 21 04:00 PM
COLLIS STEVEN HDirectorMay 20 '25Proposed Sale293.8414,5784,283,600May 20 09:45 AM
Hopfield JessicaMember of immediate family of May 19 '25Proposed Sale293.2412,1853,573,163May 19 02:29 PM
Mauch Robert P.OfficerMay 19 '25Proposed Sale291.434,9691,448,116May 19 09:51 AM
GREENBERG LON RDirectorMay 14 '25Sale279.053,000837,15017,851May 16 04:23 PM
GREENBERG LON RDirectorMay 14 '25Proposed Sale279.053,000837,150May 14 03:53 PM
COLLIS STEVEN HExecutive ChairmanApr 22 '25Option Exercise86.0912,5791,082,926330,492Apr 23 04:24 PM
COLLIS STEVEN HExecutive ChairmanApr 22 '25Sale281.8114,5794,108,508315,913Apr 23 04:24 PM
Mauch Robert P.President & CEOApr 21 '25Option Exercise86.093,225277,64052,551Apr 22 04:06 PM
Mauch Robert P.President & CEOApr 21 '25Sale289.334,9691,437,68147,582Apr 22 04:06 PM
COLLIS STEVEN HDirectorApr 22 '25Proposed Sale281.8114,5794,108,508Apr 22 09:42 AM
Mauch Robert P.OfficerApr 21 '25Proposed Sale289.334,9691,437,681Apr 21 09:48 AM
COLLIS STEVEN HExecutive ChairmanMar 25 '25Option Exercise86.0912,5781,082,840332,491Mar 26 04:40 PM
COLLIS STEVEN HExecutive ChairmanMar 25 '25Sale269.5114,5783,928,917317,913Mar 26 04:40 PM
Campbell Elizabeth SExecutive Vice PresidentMar 24 '25Sale268.284,1271,107,19214,665Mar 26 04:38 PM
COLLIS STEVEN HDirectorMar 25 '25Proposed Sale269.5114,5783,928,917Mar 25 10:16 AM
Campbell Elizabeth SOfficerMar 24 '25Proposed Sale268.284,1271,107,192Mar 24 10:53 AM
Mauch Robert P.President & CEOMar 18 '25Option Exercise86.093,226277,72654,296Mar 19 04:38 PM
Mauch Robert P.President & CEOMar 18 '25Sale260.934,9701,296,82249,326Mar 19 04:38 PM
Mauch Robert P.OfficerMar 18 '25Proposed Sale260.934,9701,296,822Mar 18 12:05 PM
Krikorian LazarusSVP & Chief Accounting OfficerMar 10 '25Sale260.062,000520,12020,154Mar 11 04:07 PM
Krikorian LazarusOfficerMar 10 '25Proposed Sale260.062,000520,120Mar 10 02:09 PM
Mauch Robert P.President & CEOMar 03 '25Option Exercise86.093,226277,72654,296Mar 04 05:35 PM
Mauch Robert P.President & CEOMar 03 '25Sale255.004,9701,267,35051,070Mar 04 05:35 PM
Mauch Robert P.OfficerMar 03 '25Proposed Sale255.004,9701,267,350Mar 03 03:28 PM
COLLIS STEVEN HExecutive ChairmanFeb 27 '25Option Exercise86.0912,5791,082,926332,492Feb 28 04:05 PM
COLLIS STEVEN HExecutive ChairmanFeb 27 '25Sale251.0814,5793,660,495319,913Feb 28 04:05 PM
COLLIS STEVEN HDirectorFeb 27 '25Proposed Sale251.0814,5793,660,495Feb 27 11:26 AM
Battaglia SilvanaExecutive Vice PresidentFeb 21 '25Sale242.245,0001,211,20015,374Feb 24 05:25 PM
Battaglia SilvanaOfficerFeb 21 '25Proposed Sale242.245,0001,211,200Feb 21 12:18 PM
Walgreens Boots Alliance, Inc.10% OwnerFeb 06 '25Sale244.511,286,376314,531,79612,570,000Feb 10 07:35 PM
Walgreens Boots Alliance HoldiAffiliateFeb 06 '25Proposed Sale246.131,081,885266,284,355Feb 06 07:55 PM
Battaglia SilvanaExecutive Vice PresidentDec 20 '24Sale228.721,678383,79220,329Dec 23 03:47 PM
Battaglia SilvanaOfficerDec 20 '24Proposed Sale228.721,678383,792Dec 20 01:48 PM
Krikorian LazarusSVP & Chief Accounting OfficerDec 03 '24Sale250.411,816454,75421,988Dec 04 04:22 PM
Krikorian LazarusOfficerDec 03 '24Proposed Sale250.421,816454,754Dec 03 11:13 AM
Cleary James FChief Financial OfficerNov 27 '24Option Exercise89.5833,8773,034,702171,508Dec 02 04:01 PM
COLLIS STEVEN HExecutive ChairmanNov 25 '24Sale243.9750,00012,198,750326,557Nov 26 04:31 PM
COLLIS STEVEN HDirectorNov 25 '24Proposed Sale243.9850,00012,198,760Nov 25 04:04 PM
COLLIS STEVEN HExecutive ChairmanNov 19 '24Option Exercise89.5821,5091,926,776328,261Nov 21 04:49 PM
COLLIS STEVEN HExecutive ChairmanNov 19 '24Sale242.1621,5095,208,619306,752Nov 21 04:49 PM
COLLIS STEVEN HDirectorNov 19 '24Proposed Sale242.1621,5095,208,619Nov 19 10:00 AM
COLLIS STEVEN HExecutive ChairmanOct 22 '24Option Exercise89.5821,5091,926,776306,597Oct 23 04:06 PM
COLLIS STEVEN HExecutive ChairmanOct 22 '24Sale235.8021,5095,071,822285,088Oct 23 04:06 PM
COLLIS STEVEN HOfficerOct 22 '24Proposed Sale235.8021,5095,071,822Oct 22 10:43 AM
COLLIS STEVEN HChairman, President & CEOSep 17 '24Option Exercise89.5821,5091,926,776306,597Sep 18 04:37 PM
COLLIS STEVEN HChairman, President & CEOSep 17 '24Sale241.0121,5095,183,884285,088Sep 18 04:37 PM
Lon GreenbergOther: BoardSep 17 '24Proposed Sale239.884,000959,520Sep 17 05:27 PM
COLLIS STEVEN HOfficerSep 17 '24Proposed Sale241.0121,5095,183,884Sep 17 09:36 AM
COLLIS STEVEN HChairman, President & CEOAug 20 '24Option Exercise89.5810,754963,343295,842Aug 21 04:08 PM
COLLIS STEVEN HChairman, President & CEOAug 20 '24Sale239.1310,7542,571,604285,088Aug 21 04:08 PM
COLLIS STEVEN HOfficerAug 20 '24Proposed Sale239.1310,7542,571,604Aug 20 10:47 AM
Battaglia SilvanaExecutive Vice PresidentAug 06 '24Sale242.691,473357,48210,948Aug 07 04:09 PM
Battaglia SilvanaOfficerAug 06 '24Proposed Sale242.691,473357,483Aug 06 02:08 PM
Walgreens Boots Alliance, Inc.10% OwnerAug 01 '24Sale240.564,438,1711,067,646,41619,980,000Aug 05 06:44 PM
Walgreens Boots Alliance HoldiAffiliateAug 01 '24Proposed Sale244.463,398,929830,902,183Aug 01 08:56 PM
COLLIS STEVEN HChairman, President & CEOJul 16 '24Option Exercise89.5810,755963,433295,843Jul 17 04:09 PM
COLLIS STEVEN HChairman, President & CEOJul 16 '24Sale222.1210,7552,388,901285,088Jul 17 04:09 PM